Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): a randomised, double-blind trial
Yi‐Long Wu(Guangdong General Hospital), Jin Soo Lee(National Cancer Center), Sumitra Thongprasert(Maharaj Nakorn Chiang Mai Hospital), Chong‐Jen Yu(National Taiwan University Hospital), Li Zhang(Sun Yat-sen University), Guia Ladrera(Lung Center of the Philippines), Vichien Srimuninnimit(Siriraj Hospital), Virote Sriuranpong(King Chulalongkorn Memorial Hospital), Jennifer Sandoval-Tan(Philippine General Hospital), Yunzhong Zhu(Beijing Chest Hospital), Meilin Liao(Shanghai Chest Hospital), Caicun Zhou(Shanghai Pulmonary Hospital), Hongming Pan(Sir Run Run Shaw Hospital), Victor Lee(Queen Mary Hospital), Yuh-Min Chen(National Yang Ming Chiao Tung University), Yan Sun(Chinese Academy of Medical Sciences & Peking Union Medical College), Benjamin Margono(Universitas Dr. Soetomo), Fatima Fuerte(University of Asia and the Pacific), Gee‐Chen Chang(National Yang Ming Chiao Tung University), Kasan Seetalarom(Phramongkutklao Hospital), Jie Wang(Peking University), A C K Cheng, Elisna Syahruddin, Xiaoping Qian, Jcm Ho(Queen Mary Hospital), Johan Kurnianda(Rumah Sakit Umum Pusat Dr. Sardjito), Hsingjin Eugene Liu(Taipei Medical University), Kate Jin(Roche (Switzerland)), Matt Truman(Roche (Switzerland)), Ilze Bāra(Roche (Switzerland)), Tony Mok(Chinese University of Hong Kong)
Cited by 304
Abstract
Related Papers
No related papers found
Powered by citation graph analysis